Glenmark gets USFDA nod to market generic diabetes drug

​​ The company has received final approval from the US Food & Drug Administration (US FDA) for Saxagliptin Tablets (2.5 mg and 5 mg), the generic version of AstraZeneca's Onglyza1 tablets, the Mumbai-based drug maker said in a statement.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/DdlbpFq
via IFTTT